WELSH , Nils. Are off-target effects of imatinib the key to improving beta-cell function in diabetes?. Upsala Journal of Medical Sciences, [S. l.], v. 127, n. 1, 2022. DOI: 10.48101/ujms.v127.8841. Disponível em: https://ujms.net/index.php/ujms/article/view/8841. Acesso em: 13 nov. 2026.